These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 15312202)

  • 1. Insulin and metabolic substrates during human sepsis.
    Finney SJ
    Crit Care; 2004 Aug; 8(4):227-8. PubMed ID: 15312202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of insulin on glucose metabolism and energy expenditure in septic patients.
    Rusavy Z; Sramek V; Lacigova S; Novak I; Tesinsky P; Macdonald IA
    Crit Care; 2004 Aug; 8(4):R213-20. PubMed ID: 15312220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thermogenic, hormonal and metabolic effects of intravenous glucose infusion in human sepsis.
    Carlson GL; Gray P; Arnold J; Little RA; Irving MH
    Br J Surg; 1997 Oct; 84(10):1454-9. PubMed ID: 9361613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbohydrate-induced thermogenesis in man.
    Jequier E
    Int J Vitam Nutr Res; 1986; 56(2):193-6. PubMed ID: 3525443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of insulin receptor substrate-1 and its serine phosphorylation and tyrosine phosphorylation on insulin resistance in skeletal muscle cells in the state of sepsis: experiment with rats].
    Yan XW; Li WQ; Wang XD; Li JS; Li N
    Zhonghua Yi Xue Za Zhi; 2006 Nov; 86(41):2922-7. PubMed ID: 17288791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulating the endocrine response in sepsis: insulin and blood glucose control.
    Vanhorebeek I; Langouche L; Van den Berghe G
    Novartis Found Symp; 2007; 280():204-15; discussion 215-22. PubMed ID: 17380796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of dopamine D2 receptors simultaneously ameliorates various metabolic features of obese women.
    Kok P; Roelfsema F; Frölich M; van Pelt J; Stokkel MP; Meinders AE; Pijl H
    Am J Physiol Endocrinol Metab; 2006 Nov; 291(5):E1038-43. PubMed ID: 16803851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic PYY3-36 treatment promotes fat oxidation and ameliorates insulin resistance in C57BL6 mice.
    van den Hoek AM; Heijboer AC; Voshol PJ; Havekes LM; Romijn JA; Corssmit EP; Pijl H
    Am J Physiol Endocrinol Metab; 2007 Jan; 292(1):E238-45. PubMed ID: 16940471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple abnormalities in glucose and energy metabolism and coordinated changes in levels of adiponectin, cytokines, and adhesion molecules in subjects with metabolic syndrome.
    Salmenniemi U; Ruotsalainen E; Pihlajamäki J; Vauhkonen I; Kainulainen S; Punnonen K; Vanninen E; Laakso M
    Circulation; 2004 Dec; 110(25):3842-8. PubMed ID: 15596567
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postoperative parenteral nutrition while proactively minimizing insulin resistance.
    Svanfeldt M; Thorell A; Nygren J; Ljungqvist O
    Nutrition; 2006 May; 22(5):457-64. PubMed ID: 16473497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pronounced elevation of resistin correlates with severity of disease in severe sepsis and septic shock.
    Sundén-Cullberg J; Nyström T; Lee ML; Mullins GE; Tokics L; Andersson J; Norrby-Teglund A; Treutiger CJ
    Crit Care Med; 2007 Jun; 35(6):1536-42. PubMed ID: 17452927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycemia influences on glucose metabolism in sepsis during hyperinsulinemic clamp.
    Rusavy Z; Macdonald IA; Sramek V; Lacigova S; Tesinsky P; Novak I
    JPEN J Parenter Enteral Nutr; 2005; 29(3):171-5. PubMed ID: 15837776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of exogenous metabolic substrate modulation on exercise-induced myocardial ischemia.
    Bogaty P; Poirier P; Boyer L; Simard S; Morin J; Dagenais GR
    Am Heart J; 2008 Oct; 156(4):790-6. PubMed ID: 18926162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased blood flow by insulin infusion targeting normoglycemia in patients with severe sepsis: friend or foe?
    Van den Berghe G
    Crit Care; 2010; 14(1):122. PubMed ID: 20236504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severity of insulin resistance in critically ill medical patients.
    Zauner A; Nimmerrichter P; Anderwald C; Bischof M; Schiefermeier M; Ratheiser K; Schneeweiss B; Zauner C
    Metabolism; 2007 Jan; 56(1):1-5. PubMed ID: 17161218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucose-insulin-potassium and reperfusion in acute myocardial infarction: rationale and design of the Glucose-Insulin-Potassium Study-2 (GIPS-2).
    van der Horst IC; Timmer JR; Ottervanger JP; Bilo HJ; Gans RO; de Boer MJ; Zijlstra F;
    Am Heart J; 2005 Apr; 149(4):585-91. PubMed ID: 15990738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in glucose metabolism in non-endocrine disease: potential implication for wasting.
    Sauerwein HP; Romijn JA
    Clin Nutr; 2001 Feb; 20(1):2-8. PubMed ID: 11161536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effects of insulin on glucose metabolism in sepsis].
    Rusavý Z; Lacigová S; Jankovec Z; Zourek M; Krcma M
    Vnitr Lek; 2006 May; 52(5):429-32; discussion 433. PubMed ID: 16771083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Energy cost of glucose storage in human subjects during glucose-insulin infusions.
    Thiebaud D; Schutz Y; Acheson K; Jacot E; DeFronzo RA; Felber JP; Jequier E
    Am J Physiol; 1983 Mar; 244(3):E216-21. PubMed ID: 6338736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic and hemodynamic effects of high-dose insulin treatment in aortic valve and coronary surgery.
    Koskenkari JK; Kaukoranta PK; Kiviluoma KT; Raatikainen MJ; Ohtonen PP; Ala-Kokko TI
    Ann Thorac Surg; 2005 Aug; 80(2):511-7. PubMed ID: 16039195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.